Endometrial ablation for dysfunctional uterine bleeding: Role of GnRH agonists
Tóm tắt
Tài liệu tham khảo
10.1016/0028-2243(86)90124-3
10.1136/bmj.294.6574.759
Mishell DR, 1987, Comprehensive Gynecology, 953
10.1111/j.1471-0528.1991.tb13460.x
10.1111/j.1471-0528.1991.tb15369.x
10.3109/00016346609158455
10.1111/j.1471-0528.1980.tb05013.x
Cameron IT, 1990, The effects of mefenamic acid and norethisterone on measured menstrual blood loss, Obstet Gynecol, 76, 85
10.1016/0002-9378(84)90123-6
10.1111/j.1471-0528.1990.tb16249.x
10.1016/0002-9378(71)90259-6
10.1161/01.STR.21.5.817
10.1016/S0002-9378(84)80039-3
10.1111/j.1471-0528.1987.tb03150.x
10.1016/S0002-9378(11)90533-X
10.1111/j.1471-0528.1980.tb04489.x
10.1136/pgmj.67.791.833
10.1111/j.1471-0528.1989.tb03325.x
Thorp JM, 1991, Submucous myomas treated with gonadotropin releasing hormone agonist and resulting in vaginal hemorrhage A case report, J Reprod Med, 36, 625
10.5694/j.1326-5377.1991.tb121094.x
10.1016/0002-9378(85)90554-X
10.3109/00016349009013304
10.1002/lsm.1900110105
Fraser HM, 1984, Effects of chronic luteinizing hormone‐releasing hormone agonist treatment on dysfunctional uterine bleeding in the stumptailed macaque, Acta Endocrinol, 106, 381
10.1111/j.1471-0528.1984.tb03708.x
10.1016/S0015-0282(16)60928-7
10.1016/S0015-0282(16)59885-9
10.1210/jcem-67-4-701
10.1016/0002-9378(82)90362-3
10.5694/j.1326-5377.1978.tb131461.x
10.1097/00006250-199011000-00022
10.2105/AJPH.70.1.40
10.5694/j.1326-5377.1991.tb121365.x
10.1016/S0002-9378(85)80067-3
10.1111/j.1471-0528.1991.tb15365.x
10.1016/S0140-6736(74)92074-1
10.1016/S0015-0282(16)49942-5
10.5694/j.1326-5377.1990.tb125382.x
Dorsey JH, 1991, Endometrial ablation, Obstet Gynecol Clin North Am, 18, 637, 10.1016/S0889-8545(21)00338-7
Droegemueller W, 1971, Cryosurgery in patients with dysfunctional uterine bleeding, Obstet Gynecol, 38, 256
10.1016/S0015-0282(16)46704-X
10.1159/000301703
10.1016/0002-9378(76)90471-3
Decherney A, 1983, Hysteroscopic management of intra‐uterine lesions and intractable uterine bleeding, Obstet Gynecol, 61, 392
10.1016/0002-9378(81)90251-9
10.1016/0140-6736(90)90207-L
10.1111/j.1471-0528.1991.tb15345.x
10.1111/j.1471-0528.1990.tb01779.x
10.1016/0002-9378(88)90512-1
Lefler HT, 1991, Modified endometrial ablation: electrocoagulation with vasopressin and suction curettage preparation, Obstet Gynecol, 77, 949
Loffer FD, 1987, Hysteroscopic endometrial ablation with the Nd:YAG laser using a nontouch technique, Obstet Gynecol, 69, 679
Ke RW, 1991, Endometrial ablation to control excessive uterine bleeding, Hum Reprod, 6, 574
Bent AE, 1990, Endometrial ablation with the neodymium: Yag laser, Obstet Gynecol, 75, 923
10.5694/j.1326-5377.1991.tb119444.x
Decherney AH, 1987, Endometrial ablation for intractable uterine bleeding: hysteroscopic resection, Obstet Gynecol, 70, 668
Serden SP, 1991, Treatment of abnormal uterine bleeding with the gynecologic resectoscope, J Reprod Med, 36, 697
McLucas B, 1990, Endometrial ablation with roller ball electrode, J Reprod Med, 35, 1055
10.1111/j.1471-0528.1989.tb03347.x
Villforth JC, 1990, FDA safety alert: gas/air embolism associated with intrauterine laser surgery, Am Coll Surg Bull, 75, 16
10.1177/0310057X9101900211
10.1016/S0001-2092(07)69290-4
10.1016/S0015-0282(16)59427-8
10.1016/0002-9378(90)90817-Q
Vancaillie TG, 1989, Electrocoagulation of the endometrium with the ball‐end resectoscope, Obstet Gynecol, 74, 425
Hoekstra PT, 1983, Transurethral prostatic resection syndrome — a new perspective: encephalopathy with associated hyperammonemia, J Urol, 130, 704, 10.1016/S0022-5347(17)51414-7
10.1097/00000542-198909000-00023
Coppinger SWV, 1989, Risk factor for myocardial infarction in transurethral resection of prostate?, Lancet, 2, 895
Townsend DE, 1990, “Rollerball” coagulation of the endometrium, Obstet Gynecol, 76, 310
10.1016/0002-9378(91)91443-Z
Brooks PG, 1991, Preparation of the endometrium for ablation with a single dose of leuprolide acetate depot, J Reprod Med, 36, 477